The oral cyclophilin inhibitor DEBIO 025 has a "significant antiviral effect" against different genotypes of the hepatitis C virus

Source: Inpharma, Volume 1, Number 1637, 2008-05-10 , pp. 8-8(1)

Publisher: Adis International

Keywords: DEBIO-025, therapeutic use; Hepatitis-C, treatment; HIV-1-infections, treatment; Research-and-development

Document Type: Research article

Links for this article

http://www.ingentaconnect.com/adis/inp/2008/00000001/00001637/art00016
http://openurl.ingenta.com/content?genre=article&issn=1173-8324&volume=1&issue=1637&spage=8&epage=8